Pages that link to "Q45304807"
Jump to navigation
Jump to search
The following pages link to Glenda Halliday (Q45304807):
Displaying 50 items.
- Missing pieces in the Parkinson's disease puzzle (Q22251063) (← links)
- Neuromelanin in human dopamine neurons: Comparison with peripheral melanins and relevance to Parkinson's disease (Q22251216) (← links)
- LRRK2 interactions with α-synuclein in Parkinson's disease brains and in cell models (Q24304959) (← links)
- c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease (Q24318974) (← links)
- Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease (Q24324577) (← links)
- p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy (Q24682056) (← links)
- The role of dysfunctional attentional control networks in visual misperceptions in Parkinson's disease (Q25894622) (← links)
- Neuronal network disintegration: common pathways linking neurodegenerative diseases (Q26750287) (← links)
- Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism (Q26782028) (← links)
- Exploring myelin dysfunction in multiple system atrophy (Q26852634) (← links)
- Alpha-synuclein biology in Lewy body diseases (Q27003541) (← links)
- Biomarkers in dementia: clinical utility and new directions (Q27007086) (← links)
- Expanding the phenotypic associations of globular glial tau subtypes (Q27315448) (← links)
- Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease (Q27686808) (← links)
- Animal modeling an oligodendrogliopathy--multiple system atrophy (Q28074659) (← links)
- GSK3B polymorphisms alter transcription and splicing in Parkinson's disease (Q28116939) (← links)
- Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation (Q28208309) (← links)
- Distribution, morphology and number of monoamine-synthesizing and substance P-containing neurons in the human dorsal raphe nucleus (Q28281755) (← links)
- Retrosplenial cortex (BA 29) volumes in behavioral variant frontotemporal dementia and Alzheimer's disease (Q28285512) (← links)
- Variability in neuronal expression of dopamine receptors and transporters in the substantia nigra (Q28290596) (← links)
- What is the dominant Abeta species in human brain tissue? A review (Q28301724) (← links)
- Language-associated cortical regions are proportionally larger in the female brain (Q28304153) (← links)
- Lipid pathway alterations in Parkinson's disease primary visual cortex (Q28386548) (← links)
- Unique transcriptome patterns of the white and grey matter corroborate structural and functional heterogeneity in the human frontal lobe (Q28534652) (← links)
- Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium (Q29614409) (← links)
- Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions (Q30434949) (← links)
- Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration (Q30503638) (← links)
- Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease. (Q30856480) (← links)
- Pathologically proven frontotemporal dementia presenting with severe amnesia (Q30979837) (← links)
- Progression in Behavioral Variant Frontotemporal Dementia: A Longitudinal Study (Q31011285) (← links)
- Neurofilament-immunoreactive neurons are not selectively vulnerable in Alzheimer's disease (Q31853647) (← links)
- Hemorrhage is uncommon in new Alzheimer family with Flemish amyloid precursor protein mutation (Q33208813) (← links)
- Antigen-epitope retrieval to facilitate proteomic analysis of formalin-fixed archival brain tissue (Q33260237) (← links)
- Pedigree with frontotemporal lobar degeneration--motor neuron disease and Tar DNA binding protein-43 positive neuropathology: genetic linkage to chromosome 9. (Q33364603) (← links)
- Dolichol is the major lipid component of human substantia nigra neuromelanin. (Q33432829) (← links)
- Investigation of the lipid component of neuromelanin. (Q33435358) (← links)
- Apolipoprotein-E forms dimers in human frontal cortex and hippocampus (Q33532794) (← links)
- Brain shrinkage in alcoholics: a decade on and what have we learned? (Q33658092) (← links)
- Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration (Q33685317) (← links)
- Classification of FTLD-TDP cases into pathological subtypes using antibodies against phosphorylated and non-phosphorylated TDP43. (Q33715607) (← links)
- ATP13A2 (PARK9) protein levels are reduced in brain tissue of cases with Lewy bodies (Q33715666) (← links)
- The neurobiological basis of cognitive impairment in Parkinson's disease (Q33724698) (← links)
- Parkinson's disease-implicated kinases in the brain; insights into disease pathogenesis (Q33797449) (← links)
- Assessment of amyloid β in pathologically confirmed frontotemporal dementia syndromes. (Q33806930) (← links)
- DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E in vitro (Q33818001) (← links)
- Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium (Q33869820) (← links)
- The relationships between mild cognitive impairment and phenotype in Parkinson's disease (Q33917203) (← links)
- Abnormal connectivity between the default mode and the visual system underlies the manifestation of visual hallucinations in Parkinson's disease: a task-based fMRI study (Q33917217) (← links)
- FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration (Q33922335) (← links)
- Frontotemporal dementia and its subtypes: a genome-wide association study (Q33955007) (← links)